Cargando…

Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors

It is of interest to elucidate the binding mode analysis of 18 sulphonated flavones in the non nucleoside inhibitory binding pocket of the HIV-1 reverse transcriptase (PDB ID: 1RTD). We further compared them with the known Non Nucleosidic Reverse Transcriptase Inhibitors (NNRTI) drug molecules such...

Descripción completa

Detalles Bibliográficos
Autores principales: Alaoui, My Abdelaziz El, Fartah, Souad El, Alaoui, Najwa, Fahime, El Mostapha El, Habsaoui, Amar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859701/
https://www.ncbi.nlm.nih.gov/pubmed/31787814
http://dx.doi.org/10.6026/97320630015646
_version_ 1783471170006286336
author Alaoui, My Abdelaziz El
Fartah, Souad El
Alaoui, Najwa
Fahime, El Mostapha El
Habsaoui, Amar
author_facet Alaoui, My Abdelaziz El
Fartah, Souad El
Alaoui, Najwa
Fahime, El Mostapha El
Habsaoui, Amar
author_sort Alaoui, My Abdelaziz El
collection PubMed
description It is of interest to elucidate the binding mode analysis of 18 sulphonated flavones in the non nucleoside inhibitory binding pocket of the HIV-1 reverse transcriptase (PDB ID: 1RTD). We further compared them with the known Non Nucleosidic Reverse Transcriptase Inhibitors (NNRTI) drug molecules such as delaviridine, nevirapine and etravirine. Molecular docking studies of sulphonated flavones were performed in the binding pocket of reverse transcriptase using the PatchDock server. The flavones have different binding energies with RT and the atomic contact energy (ACE) value of sulfonated flavones range from-389 to-231 Kcal/mol while docking of the commercialized NNRTI showed the ACE value range from -486 to -224 Kcal/mol. This shows that most sulfonated flavones have ACE similar to the known NNRTI. Thus, seven compounds (FS-6, FS-7, FS-8, FS-9, FS-14, FS-15, FS-17) were reported as potent, selective, orally bio available, and nontoxic lead based on ADMET screening and effective binding analysis in the active site of the reverse transcriptase (PDB ID: 1RTD) for further consideration. We further document that compounds (FS-1, FS-10, FS-4 and FS-12) have unfavorable binding features to be considered as leads.
format Online
Article
Text
id pubmed-6859701
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Biomedical Informatics
record_format MEDLINE/PubMed
spelling pubmed-68597012019-11-29 Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors Alaoui, My Abdelaziz El Fartah, Souad El Alaoui, Najwa Fahime, El Mostapha El Habsaoui, Amar Bioinformation Research Article It is of interest to elucidate the binding mode analysis of 18 sulphonated flavones in the non nucleoside inhibitory binding pocket of the HIV-1 reverse transcriptase (PDB ID: 1RTD). We further compared them with the known Non Nucleosidic Reverse Transcriptase Inhibitors (NNRTI) drug molecules such as delaviridine, nevirapine and etravirine. Molecular docking studies of sulphonated flavones were performed in the binding pocket of reverse transcriptase using the PatchDock server. The flavones have different binding energies with RT and the atomic contact energy (ACE) value of sulfonated flavones range from-389 to-231 Kcal/mol while docking of the commercialized NNRTI showed the ACE value range from -486 to -224 Kcal/mol. This shows that most sulfonated flavones have ACE similar to the known NNRTI. Thus, seven compounds (FS-6, FS-7, FS-8, FS-9, FS-14, FS-15, FS-17) were reported as potent, selective, orally bio available, and nontoxic lead based on ADMET screening and effective binding analysis in the active site of the reverse transcriptase (PDB ID: 1RTD) for further consideration. We further document that compounds (FS-1, FS-10, FS-4 and FS-12) have unfavorable binding features to be considered as leads. Biomedical Informatics 2019-10-12 /pmc/articles/PMC6859701/ /pubmed/31787814 http://dx.doi.org/10.6026/97320630015646 Text en © 2019 Biomedical Informatics http://creativecommons.org/licenses/by/3.0/ This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
spellingShingle Research Article
Alaoui, My Abdelaziz El
Fartah, Souad El
Alaoui, Najwa
Fahime, El Mostapha El
Habsaoui, Amar
Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors
title Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors
title_full Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors
title_fullStr Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors
title_full_unstemmed Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors
title_short Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors
title_sort molecular docking analysis of flavonoid compounds with hiv-1 reverse transcriptase for the identification of potential effective inhibitors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859701/
https://www.ncbi.nlm.nih.gov/pubmed/31787814
http://dx.doi.org/10.6026/97320630015646
work_keys_str_mv AT alaouimyabdelazizel moleculardockinganalysisofflavonoidcompoundswithhiv1reversetranscriptasefortheidentificationofpotentialeffectiveinhibitors
AT fartahsouadel moleculardockinganalysisofflavonoidcompoundswithhiv1reversetranscriptasefortheidentificationofpotentialeffectiveinhibitors
AT alaouinajwa moleculardockinganalysisofflavonoidcompoundswithhiv1reversetranscriptasefortheidentificationofpotentialeffectiveinhibitors
AT fahimeelmostaphael moleculardockinganalysisofflavonoidcompoundswithhiv1reversetranscriptasefortheidentificationofpotentialeffectiveinhibitors
AT habsaouiamar moleculardockinganalysisofflavonoidcompoundswithhiv1reversetranscriptasefortheidentificationofpotentialeffectiveinhibitors